Bettina Bannert Selected Research

Autoantibodies

1/2019	Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis.
3/2013	Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bettina Bannert Research Topics

Disease

4	Rheumatoid Arthritis 09/2023 - 01/2017
3	Rheumatic Diseases (Rheumatism) 03/2020 - 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Arthritis (Polyarthritis) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Giant Cell Arteritis (Horton Disease) 01/2022
1	Gout 01/2022
1	Atrial Fibrillation 03/2020
1	Bacterial Conjunctivitis 03/2020
1	Axial Spondyloarthritis 01/2019
1	Back Pain (Backache) 01/2019
1	Diphtheria 01/2019
1	Human Influenza (Influenza) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Ankylosing Spondylitis 01/2019
1	Tetanus 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 03/2013
1	Weight Loss (Weight Reduction) 01/2011

Drug/Important Bio-Agent (IBA)

2	Abatacept (Orencia)FDA Link 09/2023 - 08/2022
2	AutoantibodiesIBA 01/2019 - 03/2013
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	InterferonsIBA 01/2023
1	AutoantigensIBA 01/2023
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2023
1	CytokinesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Chemotactic FactorsIBA 01/2022
1	ChemokinesIBA 01/2022
1	iscalimabIBA 03/2020
1	AntigensIBA 01/2019
1	petesicatibIBA 01/2019
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019
1	cathepsin SIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019
1	Diphtheria-Tetanus VaccineIBA 01/2019
1	Cysteine Proteases (Cysteine Protease)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2018
1	tofacitinibIBA 01/2017
1	Janus Kinase InhibitorsIBA 01/2017
1	AntibodiesIBA 03/2013

Therapy/Procedure

2	Therapeutics 09/2023 - 01/2011